amniox
-
Biologics
AMNIOX Obtains Federal Supply Schedule Contract for NEOX® and CLARIX® Product Lines
April 17, 2017 ATLANTA–(BUSINESS WIRE)–AMNIOX Medical, Inc., a TissueTech, Inc. company, announced a new Federal Supply Schedule contract for its…
Read More » -
Biologics
AMNIOX Highlights Study Demonstrating Improved Outcomes in Patients Treated with CLARIX® Regenerative Matrix as an Adjunct to Lumbar Discectomy
October 26, 2016 ATLANTA–(BUSINESS WIRE)–AMNIOX Medical, Inc., a TissueTech™, Inc., company, announced the results of a prospective randomized clinical study…
Read More » -
Extremities
AMNIOX Highlights Studies Finding CLARIX® FLO and CLARIX® CORD 1K Improving Foot and Ankle Outcomes
AMNIOX Medical, Inc., a TissueTech, Inc. company, highlighted the results of two studies presented at the American Orthopaedic Foot &…
Read More » -
Biologics
Palmetto Medicare Now Covering Amniox Medical Products
ATLANTA–(BUSINESS WIRE)–AMNIOX Medical, Inc., a TissueTech, Inc. company, announced that Palmetto Medicare recently released its new Skin Substitute medical policy,…
Read More » -
Extremities
Amniox Medical touts foot ulcer study data
Amniox Medical today released results from a retrospective study of its Neox wound allograft in treating chronic diabetic foot ulcers…
Read More » -
Biologics
Amniox Medical Appoints Thomas J. Dugan as Chief Executive Officer
ATLANTA & MIAMI — Amniox Medical, Inc. (“Amniox”, the “Company”), a leading provider of amniotic membrane based products for wound…
Read More » -
Amniox Medical Brings Revolutionary Amniotic Membrane Technology to the Forefront of Podiatry
Amniox launching NEOXTM Grafts at the American College of Foot and Ankle Surgeons Annual Scientific Conference Amniox Medical, Inc., a leader in Amnion…
Read More »